| Product Code: ETC6174050 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Angioedema Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Angioedema Market - Industry Life Cycle |
3.4 Australia Angioedema Market - Porter's Five Forces |
3.5 Australia Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Australia Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Australia Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Australia Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Australia Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Australia Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about angioedema among healthcare professionals and patients |
4.2.2 Advancements in medical technologies for diagnosis and treatment of angioedema |
4.2.3 Growing prevalence of angioedema in Australia due to various factors such as genetics and environmental triggers |
4.3 Market Restraints |
4.3.1 High cost associated with angioedema treatments and medications |
4.3.2 Limited availability of specialized healthcare facilities for angioedema management in certain regions of Australia |
4.3.3 Challenges in accurately diagnosing angioedema due to its variable presentation and similarity to other conditions |
5 Australia Angioedema Market Trends |
6 Australia Angioedema Market, By Types |
6.1 Australia Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Australia Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Australia Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Australia Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Australia Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Australia Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Australia Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Australia Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Australia Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Australia Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Australia Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Australia Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Australia Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Australia Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Australia Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Australia Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Australia Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Australia Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Australia Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Australia Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Australia Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Australia Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Australia Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Australia Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Australia Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Australia Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Australia Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Australia Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Australia Angioedema Market Import-Export Trade Statistics |
7.1 Australia Angioedema Market Export to Major Countries |
7.2 Australia Angioedema Market Imports from Major Countries |
8 Australia Angioedema Market Key Performance Indicators |
8.1 Average time taken for diagnosis and treatment initiation of angioedema cases |
8.2 Number of new research studies and clinical trials focused on angioedema in Australia |
8.3 Patient satisfaction rates with the quality of care and support received for angioedema management |
8.4 Percentage of healthcare professionals trained in recognizing and managing angioedema cases |
8.5 Rate of adoption of newer, more effective treatments for angioedema in the Australian market |
9 Australia Angioedema Market - Opportunity Assessment |
9.1 Australia Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Australia Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Australia Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Australia Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Australia Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Australia Angioedema Market - Competitive Landscape |
10.1 Australia Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Australia Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here